Michal Eisenbach-Schwartz,Kuti Baruch,Neta Rosenzweig
申请号:
US15698800
公开号:
US20180009893A1
申请日:
2017.09.08
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present specification discloses a pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS. The pharmaceutical composition is administered by a dosage regimen comprising at least one course of therapy, each course of therapy comprising in sequence a treatment session followed by an interval session of non-treatment.